… definitively diagnose and track disease, stratify clinical research volunteers and test disease-modifying therapies. … testing presents a catch-22: providers will pay if diagnosis and disease tracking can lead to a beneficial treatment, but researchers need data from diagnostic and tracking tools to …

… Objective/Rationale:  The diagnosis of Parkinson disease is based on clinical criteria … currently no accepted biological markers to assist in the diagnosis of PD. Oxidative stress (free radical damage) has … we anticipate that plasma NIR spectroscopy will distinguish early PD from healthy individuals with 80% accuracy or …

… effort to translate these exploratory results obtained with research use-only assays (first generation) to a more robust … the prototype test will be further developed into a robust assay. Special attention will be given to high … protein, modified forms, aggregated isoforms). Impact on Diagnosis/Treatment of Parkinson’s Disease:              The …

… future studies that will increase their chance of success.” Researchers recently announced that SURE-PD3, a Phase III … solid trial design and measurement tools and the value of research participation. Though the outcome is not what … taking placebo. The SURE-PD3 trial is being conducted at nearly 60 sites across the United States and is funded by the …

… of its performance in a larger group of PwP. Impact on Diagnosis/Treatment of Parkinson’s disease:              … effects for a novel intervention designed for an early disease stage, with particular relevance for the … Research Grant …

… on foot, Team Big B turned an extreme endurance challenge into a powerful tribute — honoring Brian "Big B" Adam and raising more than $256,000 for Parkinson’s research.   Brian was Nick’s uncle, Jeff’s father-in- law … was the 100-mile experience like?   Jeff: We knew pretty early on that the day wasn’t going to go as planned. It …